Schwermann Jessica, Rathinam Chozhavendan, Schubert Maria, Schumacher Stefanie, Noyan Fatih, Koseki Haruhiko, Kotlyarov Alexey, Klein Christoph, Gaestel Matthias
Institute of Biochemistry, Hannover Medical School, Hannover, Germany.
EMBO J. 2009 May 20;28(10):1392-406. doi: 10.1038/emboj.2009.100. Epub 2009 Apr 16.
The structurally related MAPK-activated protein kinases (MAPKAPKs or MKs) MK2, MK3 and MK5 are involved in multiple cellular functions, including cell-cycle control and cellular differentiation. Here, we show that after deregulation of cell-cycle progression, haematopoietic stem cells (HSCs) in MK2-deficient mice are reduced in number and show an impaired ability for competitive repopulation in vivo. To understand the underlying molecular mechanism, we dissected the role of MK2 in association with the polycomb group complex (PcG) and generated a MK2 mutant, which is no longer able to bind to PcG. The reduced ability for repopulation is rescued by re-introduction of MK2, but not by the Edr2-non-binding mutant of MK2. Thus, MK2 emerges as a regulator of HSC homeostasis, which could act through chromatin remodelling by the PcG complex.
结构相关的丝裂原活化蛋白激酶(MAPKAPK或MK)MK2、MK3和MK5参与多种细胞功能,包括细胞周期控制和细胞分化。在此,我们表明,在细胞周期进程失调后,MK2缺陷小鼠中的造血干细胞(HSC)数量减少,且在体内表现出竞争性再增殖能力受损。为了解潜在的分子机制,我们剖析了MK2与多梳蛋白组复合体(PcG)相关的作用,并生成了一个不再能够与PcG结合的MK2突变体。通过重新引入MK2可挽救再增殖能力的降低,但MK2的Edr2非结合突变体则不能。因此,MK2成为HSC稳态的调节因子,其可能通过PcG复合体进行染色质重塑发挥作用。